Fernando Carnicero-González

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

M. Lejeune, M. Sánchez-Beato, V. Sánchez-Margalet, 2021, Journal for ImmunoTherapy of Cancer.

CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma

M. Sánchez-Beato, D. Rodríguez-Abreu, D. J. García-Domínguez, 2024, Frontiers in immunology.